CEO Shaw to leave Ambri
Monday, 24 March, 2003
Dr Joe Shaw, the managing director and CEO of Sydney-based biosensor specialist Ambri (ASX: ABI), has resigned from the company and will return to the US.
He will be replaced at the helm by non-executive director David Cornelius until a new, permanent CEO can be found. Cornelius is on secondment from his position as executive director of Ambri partner Dow Corning's new ventures division.
Shaw, who joined the company almost four years ago, had helped usher in "substantial progress towards commercialisation" of Ambri's biosensor technology, said company chairman Dr John Eady in a statement.
He said Cornelius, with the help of new COO Dr Jonathan Wright, would "provide new and valuable skills and experience needed to lead Ambri through the next phases pf its development."
Shaw said he expected to return to the US at Easter but said he would not comment further at this time. Cornelius was not available for comment by press time.
Stem cell experiments conducted in space
Scientists are one step closer to manufacturing stem cells in space — which could speed up...
Plug-and-play test evaluates T cell immunotherapy effectiveness
The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...
